未登录

C

Cari Berget

University of Colorado System

H指数:28

被引数:2,939

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe

使用Omnipod® 5自动化胰岛素输注系统的实际考量：来自美国和欧洲的临床经验

DIABETES OBESITY & METABOLISM

IF5.7

2025-04-020

PRE

Use of an Advanced Hybrid Closed Loop System During Marathon Running: Case Examples and Clinical Implications

使用先进混合闭环系统进行马拉松跑步：案例示例和临床意义

DIABETES-METABOLISM RESEARCH AND REVIEWS

IF6

2025-02-280

PRE

Mixed Methods Randomized Controlled Trial Comparing Quality of Life for Pregnant Women With Type 1 Diabetes Using Hybrid Closed-Loop to Sensor-Augmented Pump Therapy

混合方法随机对照试验：比较使用混合闭环系统与传感器增强型泵疗法的1型糖尿病孕妇的生活质量

ENDOCRINE PRACTICE

IF4.6

2025-01-011

PRE

Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions

实时连续血糖监测仪在小儿糖尿病酮症酸中毒入院中的准确性

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2024-09-012

PRE

Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes

Omnipod的真实世界证据®5自动胰岛素输送系统在69,902名1型糖尿病患者中的应用

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2024-08-0118

OA

The Use of Hybrid Closed-Loop Insulin Delivery in Adolescents and Young Adults with High-Risk Acute Lymphoblastic Leukemia during Induction Chemotherapy

IF7.5

2024-06-140

PRE

Real-World Outcomes with the Omnipod 5 Automated Insulin Delivery (AID) System for >7,500 Users with High HbA1c (>9%) at Baseline

IF7.5

2024-06-140

PRE

Understanding Patterns of GLP-1/GLP-1 RA Use among Individuals with Type 1 Diabetes-A T1D Exchange (T1DX) Online Registry Analysis

IF7.5

2024-06-140

PRE

Virtual and Self-Guided Omnipod 5 Automated Insulin Delivery (AID) System Onboarding-Real-World Outcomes by Training Type

IF7.5

2024-06-140

PRE

Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2024-02-013

PRE

Accuracy of Dexcom G6 Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions

IF7.5

2023-06-200

PRE

Assessment of Eating Disorder Risk in Adolescents and Young Adults Starting an On-Body Automated Insulin Delivery (AID) System

IF7.5

2023-06-200

PRE

Preliminary Accuracy Analysis of a Noninvasive Optical Glucose Sensing Prototype

IF7.5

2023-06-200

PRE

Glycemic Control with Extended Use of Automated Insulin Delivery (AID) in Children Age 2-6 Years with Type 1 Diabetes (T1D)

IF7.5

2023-06-203

PRE

Hybrid Closed-Loop Systems to Date: Hype Versus Reality

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2023-01-012

PRE

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

ISPAD临床实践共识指南2022: 糖尿病技术: 胰岛素输送

PEDIATRIC DIABETES

IF5.6

2022-12-0597

OA

Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study

预测第一代混合闭环人工胰腺系统在儿童、青少年和年轻成人1型糖尿病患者中的成功率: 模型开发和验证研究

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2022-03-019

OA

Evaluation of a New Clinical Tool to Enhance Clinical Care of Control-IQ Users

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY

IF3.7

2022-02-280

OA

Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes

在现实世界中使用新的混合闭环可改善1型糖尿病青年的血糖控制

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2021-12-0154

OA

Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed-loop use

混合闭环在青少年，年轻人，成年人和1型糖尿病的老年人中的真实表现: 确定混合闭环使用的临床目标

DIABETES OBESITY & METABOLISM

IF5.7

2021-06-0935

PREAI